Aly Lopez-Aguiar, MD, MS, FACS
Health Sciences Assistant Clinical Professor, Surgery
School of Medicine
School of Medicine
B.A., Princeton University, 2009, English Literature
M.D., Geisel School of Medicine at Dartmouth, 2014, Medicine
M.S., Emory University Laney Graduate School, 2018, Clinical Research
Emory University School of Medicine, 2021, Residency in General Surgery
The Ohio State University James Comprehensive Cancer Center, 2023, Fellowship in Complex General Surgical Oncology
M.D., Geisel School of Medicine at Dartmouth, 2014, Medicine
M.S., Emory University Laney Graduate School, 2018, Clinical Research
Emory University School of Medicine, 2021, Residency in General Surgery
The Ohio State University James Comprehensive Cancer Center, 2023, Fellowship in Complex General Surgical Oncology
Email: lopezagu@uci.edu
University of California, Irvine
3800 W Chapman Ave
Ste 6200
Orange, CA 92868
3800 W Chapman Ave
Ste 6200
Orange, CA 92868
Research Interests
Hormone positive breast cancer, hormone negative breast cancer, inflammatory breast cancer, DCIS
Awards and Honors
- Tuition Scholarship, NIH/Atlanta Clinical and Translational Science Institute (ACTSI) (2016-2018)
- Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology (2017)
- Steve Sotsky Pancreatic Cancer Research Award, Americas Hepato-Pancreato-Biliary Association (2018)
- Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology (2018)
- Eleanor Main Graduate Student Mentor Award Nominee, Emory University (2018)
- Outstanding Poster Award, Connective Tissue Oncology Society (CTOS) (2022)
- Patient Experience MVP, University of Miami (Spring 2025)
- Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology (2017)
- Steve Sotsky Pancreatic Cancer Research Award, Americas Hepato-Pancreato-Biliary Association (2018)
- Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology (2018)
- Eleanor Main Graduate Student Mentor Award Nominee, Emory University (2018)
- Outstanding Poster Award, Connective Tissue Oncology Society (CTOS) (2022)
- Patient Experience MVP, University of Miami (Spring 2025)
Short Biography
Alexandra Lopez-Aguiar, MD, MS, FACS, is a board-certified general surgeon and complex surgical oncologist with a passion for the multimodal treatment of breast cancer. Originally from Miami, Florida, she obtained her undergraduate degree from Princeton University and her medical degree from the Geisel School of Medicine at Dartmouth University. She then completed seven years of General Surgery training at Emory University School of Medicine followed by a two-year Complex General Surgical Oncology fellowship at The Ohio State University James Comprehensive Cancer Center. Her specific areas of expertise include hormone positive and negative breast cancer, inflammatory breast cancer, genetic mutations that increase the risk of cancer, and sentinel lymph node biopsies. She has a strong interest in survivorship programs among cancer patients, as well as clinical trials evaluating the targeted treatment of breast cancer. She is dedicated to taking an individualized and multidisciplinary approach to each of her patients as she aims to improve their quality of life.
Publications
1. Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantel SJ, Andrew AS, Memoli V, Dmitrovsky E. Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target. Mol Cancer Ther 2012; 11: 1968-1977. PMID: 22752428.
2. Ma T, Lopez-Aguiar AG, Li A, Lu Y, Sekula D, Nattie EE, Freemantle S, Dmitrovsky E. Mice Lacking GOS2 are Lean and Cold-tolerant. Cancer Biol Ther 2014; 15 (5): 643-650. PMID: 24556704.
3. Ethun CG, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Idrees K, Fields RC, Weber SM, Cho C, Martin RC, Scoggins CR, Shen P, Schmidt C, Hatzaras I, Bentrem D, Ahmad S, Abbott D, Kim HJ, Merchant N, Staley CA, Kooby DA, Maithel SK. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium. J Am Coll Surg. 2017 Apr; 224 (4):406-413. PMID: 28017812.
4. Ethun CG, Le N, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Russell MC, Maithel SK. Pathologic and Prognostic Implications of Incidental vs. Non-Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Am Surg. 2017 Jul; 83 (7):679-686. PMID: 28738935.
5. Broecker JS, Ethun CG, Monson DK, Lopez-Aguiar AG, Le N, McInnis MR, Reimer NB, Oskouei SV, Delman KA, Staley CA, Maithel SK, Cardona K. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas. Ann Surg Oncol. 2017 Nov; 24 (12):3574-3586. PMID: 28895084.
6. Lopez-Aguiar AG, Ethun CG, Postlewait LM, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Maithel SK, Cardona K. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving its Prognostic Value for Recurrence of Disease. Ann Surg Oncol. 2018 Jan; 25(1): 290-298. PMID: 29079920.
7. Merath K, Bagante F, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Nomogram Predicting the Risk of Recurrence after Curative-Intent Resection of Primary Non-metastatic Gastrointestinal Neuroendocrine Tumors: An Analysis of the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol. 2018 Apr; 117(5):868-878. PMID: 29448303.
8. Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018 May; 267(5):797-805. PMID: 29064885.
9. Lopez-Aguiar AG, Ethun CG , Le N, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Association of Perioperative Transfusion with Survival and Recurrence after Resection of Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. J Surg Oncol. 2018 Jun; 117(8):1638-1647. PMID: 29761515.
10. Oh G, Farley CR, Lopez-Aguiar AG, Russell MC, Delman KA, Lowe MC. Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin. Am Surg. 2018 Aug; 84(8):1319-1325. PMID: 30185309.
11. Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK. Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg. 2018 Sep; 227(3):357-366. PMID: 29906615.
12. Dhar VK, Merchant NB, Patel SH, Edwards MJ, Wilma K, Imbus J, Abbott DE, Weber SM, Louie R, Kim HJ, Martin RCG, Scoggins CR, Bentrem DJ, LeCompte MT, Idrees K, Lopez-Aguiar AG, Maithel SK, Kooby DA, Franco DA, Yakoub D, Ahmad SA. Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study. Ann Surg. 2018 Sep; 268(3): 469-478. PMID: 30063495.
13. Lopez-Aguiar AG, Cardona K. ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2018 Dec; 25(Suppl 3):826-827. PMID: 30456670.
14. Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. J Gastrointest Surg. 2019 Jan; 23(1):122-134. PMID 30334178.
15. Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK; and other members of the US Neuroendocrine Tumor Study Group. The Impact of Failure to Achieve Symptom Control after Resection of Functional Neuroendocrine Tumors: An 8-Institution Study from the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2019 Jan; 119(1): 5-11. PMID: 30481383.
16. Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors. JAMA Surg. 2019 Feb; 154(2):134-140. PMID: 30383112.
17. Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G, Shaffer VO, Staley CA, Srinivasan J, Maithel SK, Sullivan PS. Caution: Increased Acute Kidney Injury in Enhanced Recovery after Surgery (ERAS) Protocols. Am Surg. 2019 Feb; 85(2):156-161. PMID: 30819291.
18. Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin Status and Long-Term Prognosis of Primary Pancreatic Neuroendocrine Tumor after Curative Resection: Results from the US Neuroendocrine Tumor Study Group. Surgery. 2019 Mar; 165(3):548-556. PMID 30278986.
19. Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of Carcinoid Syndrome on the Clinical Characteristics and Outcomes of Patients with Gastroenteropancreatic Neuroendocrine Tumors undergoing Operative Resection. Surgery. 2019 Mar; 165(3):657-663. PMID: 30377003.
20. Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2019 Apr; 23(4): 651-658. PMID: 30659439.
21. Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Gastric Carcinoids: Does Type of Surgery or Tumor Affect Survival? Am J Surg. 2019 May; 217(5):937-942. PMID: 30686481.
22. Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2019 Jun; 26(6):1814-1823. PMID: 30877497.
23. Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, Fields RC, Idrees K, Cho CS, Abbott DE, Cardona K, Maithel SK. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. Surgery. 2019 Jul; 166(1): 15-21. PMID: 31072670.
24. Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group. Minimally Invasive versus Open Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Analysis from the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol. 2019 Aug; 120(2):231-240. PMID: 31001868.
25. Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Ann Surg Oncol. 2019 Aug; 26(8):2517-2524. PMID: 31004295.
26. Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Ann Surg. 2019 Sep; 270(3):422-433. PMID: 31283562.
27. Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC. Association of Preoperative Monocyte-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratio with Recurrence-free and Overall Survival after Resection of Pancreatic Neuroendocrine Tumors (US-NETSG). J Surg Oncol. 2019 Sep; 120(4):632-638. PMID: 31339198.
28. Duininck G, Lopez-Aguiar AG, Lee RM, Miller L, Dariushnia S, Wu C, Alese OB, Lin JY, Wedd J, Adams A, Maithel SK, Russell MC. Optimizing Cancer Care for Hepatocellular Carcinoma at a Safety-Net Hospital: The Value of a Multidisciplinary Disease Management Team. J Surg Oncol. 2019 Oct 22. doi: 10.1002/jso.25738. [Epub ahead of print]. PMID: 31642056.
29. Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. J Gastrointest Surg. 2019 Nov; 23(11):2225-2231. PMID: 30941685.
30. DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC and other members of the United States Neuroendocrine Tumor Study Group. Interaction of Race and Pathology for Neuroendocrine Tumors: Epidemiology, Natural History, or Racial Disparity? J Surg Oncol. 2019 Nov; 120(6):919-925. PMID: 31385621.
31. Lopez-Aguiar AG, Maithel SK. ASO Author Reflections: Association of Perioperative Red Blood Cell Transfusion with Increased Disease Recurrence and Worse Survival after Resection of Distal Cholangiocarcinoma. Ann Surg Oncol. 2019 Dec; 26(Suppl 3):654-655. doi: 10.1245/s10434-019-07613-3. PMID: 31286311.
32. Lopez-Aguiar AG, Maithel SK. ASO Author Reflections: Lymph Node Metastasis and the Role for Lymphadenectomy During Surgery for Nonfunctional Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2019 Dec;26(Suppl 3):700-701. doi: 10.1245/s10434-019-07746-5. PMID: 31440924.
33. Ethun CG, Lopez-Aguiar AG, Switchenko JM, Gillespie TW, Delman KA, Staley CA, Maithel SK, Cardona K. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database. Ann Surg Oncol. 2019 Dec; 26(13):4723-4729. PMID: 31502023.
34. Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. Am Surg. 2019 Dec 1;85(12):1334-1340. PMID: 31908214.
35. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM. Resection of Pancreatic Neuroendocrine tumors: Defining Patterns and Time Course of Recurrence. HPB (Oxford). 2020 Feb; 22(2):215-223. doi: 10.1016/j.hpb.2019.05.020. PMID: 31235429.
36. Lopez-Aguiar AG, Maithel SK. Response to a Letter to the Editor: “The Cononundrum of <2 cm Pancreatic Neuroendocrine Tumors: A Preoperative Risk Score to Predict Lymph Node Metastases and Guide Surgical Management.” Surgery. 2020 Feb;167(2):514-515. doi: 10.1016/j.surg.2019.09.009. PMID: 31653493.
37. Monteiro De Barros J, Hodson J, Glasbey J, Massey R, Rintoul-Hoad O, Chetan M, Desai A, Almond LM, Gourevitch D, Ford SJ, Strauss D, Smith H, Hayes A, Cardona K, Lopez-Aguiar A, Johnson A, Swallow C, Burtenshaw S, Nessim C, Weng R, Purgin B, Gronchi A, Fiore M, Callegaro D, Raut CP, Fairweather M, Bagaria S, Novak M, Gyorki D, Reid F, Mullinax J, Gonzalez RJ, Van Coevorden F, Van Houdt W, Haas RLM, Van Boven H, Heeres B. Intercontinental Collaborative Experience with Abdominal, Retroperitoneal and Pelvic Schwannomas. Br J Surg. 2020 Mar;107(4):452-463. doi: 10.1002/bjs.11376. PMID: 31736066.
38. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Ann Surg Oncol. 2020 Apr;27(4):1203-1212. doi: 10.1245/s10434-019-08120-1. PMID: 31838609.
39. Lopez-Aguiar AG, Postlewait LM, Ethun CG, Zaidi MY, Zhelnin K, Krasinskas A, Russell MC, Kooby DA, Cardona K, El-Rayes BF, Maithel SK. STAT3 Inhibition for Gastroenteropancreatic Neuroendocrine Tumors: Potential for a New Therapeutic Target? J Gastrointest Surg. 2020 May; 24(5):1138-1148. doi: 10.1007/s11605-019-04261-6. PMID: 31144189.
40. Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, Cannon J, Poultsides GA, Rocha F, Crown A, Beal E, Michael Pawlik T, Fields R, Panni RZ, Smith P, Idrees K, Cho C, Beems M, Maithel S, Weber S, Erik Abbott D. Adjuvant Therapy Following Resection of Gastroenteropancreatic Neuroendocrine Tumors Provides No Recurrence or Survival Benefit. J Surg Oncol. 2020 Jun;121(7):1067-1073. doi: 10.1002/jso.25896. PMID: 32153032.
41. Marincola Smith P, Baechle J, Solorzano CC, Tan M, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho C, Bees M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Perioperative Blood Transfusion on Survival in Pancreatic Neuroendocrine Tumor Patients: Analysis from the US Neuroendocrine Study Group. HPB (Oxford). 2020 Jul;22(7):1042-1050. doi: 10.1016/j.hpb.2019.10.2441. PMID: 31806388.
42. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Tumor Burden Score Predicts Tumor Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection. HPB (Oxford). 2020 Aug; 22(8): 1149-1157. doi: 10.1016/j.hpb.2019.11.009. PMID: 31822386.
43. Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel SK, Rocha FG. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes? J Gastrointest Surg. 2020 Sep; 24(9): 2121-2126. doi: 10.1007/s11605-019-04431-6. PMID: 31749094.
44. Marincola Smith P, Baechle J, Tan MC, Solórzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho CS, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2020 Sep; 27(9): 3147-3153. doi: 10.1245/s10434-020-08359-z. PMID: 32219725.
45. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Spolverato G, Maithel SK, Pawlik TM. Surgical Outcomes of Patients with Duodenal vs Pancreatic Neuroendocrine Tumors Following Pancreatoduodenectomy. J Surg Oncol. 2020 Sep; 122(3): 442-449. doi: 10.1002/jso.25978. PMID: 32470159.
46. Baechle JJ, Marincola Smith P, Tan M, Solórzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Makris E, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields R, Maithel SK, Bailey CE, Idrees K. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Ann Surg Oncol. 2020 Oct; 27(10): 3915-3923. doi: 10.1245/s10434-020-08497-4. PMID: 32328982.
47. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields RC, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Ann Surg Oncol. 2020 Dec; 27(Suppl 3): 969. doi: 10.1245/s10434-020-08397-7. PMID: 32342296.
48. Gamboa AC, Ethun CG, Postlewait LM, Lopez-Aguiar AG, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Cardona K, Maithel SK. HSP90 Expression and Early Recurrence in Gastroenteropancreatic Neuroendocrine Tumors: Potential for a Novel Therapeutic Target. Surg Oncol. 2020 Dec; 35: 460-465. doi: 10.1016/j.suronc.2020.09.018. PMID: 33080545.
49. Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Dillhoff M, Lopez-Aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Indications and Outcomes of Enucleation versus Formal Pancreatectomy for Pancreatic Neuroendocrine Tumors. HPB (Oxford). 2021 Mar; 23(3):413-421. doi: 10.1016/j.hpb.2020.06.015. PMID: 32771338.
50. Heidsma CM, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Poultsides GA, Cho CS, Lopez-Aguiar AG, Kanji Z, Fisher AV, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine TumorsL A Multi-Institutional Study. Cancers (Basel). 2021 May 7; 13(9):2242. doi: 10.3390/cancers13092242. PMID: 34067017.
51. Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Ann Surg. 2021 Jul 1; 274(1):e28-e35. doi: 10.1097/SLA.0000000000003478. PMID: 31356277.
52. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model. World J Surg. 2021 Jul; 45(7): 2134-2141. doi: 10.1007/s00268-021-06020-8. PMID: 33768309.
53. Sahara K, Tsilimigras DI, Moro A, Mehta R, Dillhoff M, Heidsma CM, Lopez-Aguiar AG, Maithel SK, Rocha F, Kanji Z, Abbott DE, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho CS, Beems M, Endo I, Pawlik TM. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group. Neuroendocrinology. 2021; 111(1-2): 129-138. doi: 10.1159/000506399. PMID: 32040951.
54. Casadei L, de Faria FCC, Lopez-Aguiar A, Pollock RE, Grignol V. Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma. Cancers (Basel). 2022 Mar 8; 14(6): 1362. doi: 10.3390/cancers14061362. PMID: 35326514.
55. Zheng-Pywell R, Lopez-Aguiar A, Fields RC, Vickers S, Yates C, Dudeja V, Chen H, Reddy S, Maithel SK, Rose JB. Are We Undertreating Black Patients with Nonfunctional Pancreatic Neuroendocrine Tumors? Critical Analysis of Current Surveillance Guidelines by Race. J Am Coll Surg. 2022 Apr 1; 234(4): 599-606. doi: 10.1097/XCS.0000000000000105. PMID 35380181.
56. Zhang XF, Xue F, Wu Z, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanj Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lyu Y, Maithel SK, Pawlik TM. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors. Ann Surg. 2022 Jun 1; 275(6):e773-e780. doi: 10.1097/SLA.0000000000004039. PMID: 32511134.
57. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy versus Right Hemicolectomy. J Gastrointest Surg. 2022 Jun; 26(6): 1266-1274. doi: 10.1007/s11605-022-05269-1. PMID: 35149952.
58. Grignol VP, Lopez-Aguiar AG. The Implications of an Unplanned Sarcoma Excision (the “Whoops” Operation). Surg Clin North Am. 2022 Aug; 102(4): 529-538. doi: 10.1016/j.suc.2022.04.002. PMID: 35952685.
59. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical Outcomes of Gastro-entero-pancreatic Neuroendocrine Tumors G3 versus Neuroendocrine Carcinoma. J Surg Oncol. 2022 Sep; 126(4): 689-697. doi: 10.1002/jso.26928. PMID: 35616186.
60. Makris EA, Cannon JGD, Norton JA, Lopez-Aguiar AG, Dillhoff M, Beal E, Idrees K, Smith PM, Rocha FG, Kanji Z, Cho C, Beems M, Weber S, Fisher A, Krasnick BA, Fields RC, Maithel SK, Poultsides GA. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2023 Apr; 30(4): 2424-2430. doi: 10.1245/s10434-022-12783-8. PMID: 36434481.
61. Guo M, Leuschner T, Lopez-Aguiar A, Dillhoff M, Ejaz A, Pawlik TM, Cloyd JM. Aborted Cancer Surgery at a Single Tertiary Cancer Center: Rates, Reasons, and Outcomes. Surgery. 2023 Oct; 174(4): 880-885. doi: 10.1016/j.surg.2023.06.026. PMID: 37482440.
62. Stevens L, Wells-Di Gregorio S, Lopez-Aguiar AG, Khatri R, Ejaz A, Pawlik TM, Scott E, Kale S, Cloyd JM. Patient Experiences After Aborted Cancer Surgery: A Qualitative Study. Ann Surg Oncol. 2023 Oct; 30(11): 6844-6851. doi: 10.1245/s10434-023-14046-6. PMID: 37540329.
63. Xiang JX, Qian YR, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Low Prognostic Nutritional Index is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-entero-pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2024; 114(2): 158-169. doi: 10.1159/000534075. PMID: 37703840.
64. Lopez-Aguiar AG, Sarna A, Wells-DiGregorio S, Huang E, Kneuertz PJ, Beane J, Kim A, Ejaz A, Pawlik TM, Cloyd JM. Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of a Society of Surgical Oncology Member Survey. Ann Surg Oncol. 2024 Apr; 31(4): 2295-2302. doi: 10.1245/s10434-023-14804-6. PMID: 38127216.
65. Xiang JX, Nan YL, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Preoperative Anemia: Impact on Short- and Long-term Outcomes Following Curative-Intent Resection of Gastroenteropancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2024 Jun 13:S1091-255X(24)00366-4. doi: 10.1016/j.gassur.2024.03.014. PMID: 38538480.
66. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors. J Surg Oncol. 2025 Mar; 131(3):473-480. doi: 10.1002/jso.27951. PMID: 39387595.
67. Kesmodel SB, Lopez-Aguiar A, Grossman J, Zhao W, Koru-Sengul T, Tang J, Nouri K, Hernandez-Aya L, Lutzky J, Crystal JS. Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma. J Am Coll Surg. 2025 Oct 10. 10.1097/XCS.0000000000001657. Online ahead of print. PMID: 41071542.
68. Xu H, Hou JJ, Xiang JX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical Resection. Ann Surg Oncol. 2025 Oct 16. doi: 10.1245/s10434-025-18561-6. Online ahead of print.PMID: 41102572.
69. Xu H, Hou JJ, Xiang JX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. ASO Visual Abstract: Perineural Invasion Worsens Long-Term Outcome of Pancreatic Neuroendocrine Tumors Following Surgical Resection. Ann Surg Oncol. 2025 Nov 11. doi: 10.1245/s10434-025-18725-4. Online ahead of print. PMID: 41217677.
70. Lopez-Aguiar AG, Xu M, Kim HG, Liebner D, Grignol VP, Tinoco G. Association Between Area Deprivation Index (ADI) and Initial Treatment Among Patients with Desmoid Tumors. Surg Oncol Insight. 2026 Mar; 3(1):100216. doi: 10.1016/j.soi.2026.100216. Epub 2026 Jan 16. PMID: 41859005.
2. Ma T, Lopez-Aguiar AG, Li A, Lu Y, Sekula D, Nattie EE, Freemantle S, Dmitrovsky E. Mice Lacking GOS2 are Lean and Cold-tolerant. Cancer Biol Ther 2014; 15 (5): 643-650. PMID: 24556704.
3. Ethun CG, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Idrees K, Fields RC, Weber SM, Cho C, Martin RC, Scoggins CR, Shen P, Schmidt C, Hatzaras I, Bentrem D, Ahmad S, Abbott D, Kim HJ, Merchant N, Staley CA, Kooby DA, Maithel SK. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium. J Am Coll Surg. 2017 Apr; 224 (4):406-413. PMID: 28017812.
4. Ethun CG, Le N, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Russell MC, Maithel SK. Pathologic and Prognostic Implications of Incidental vs. Non-Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Am Surg. 2017 Jul; 83 (7):679-686. PMID: 28738935.
5. Broecker JS, Ethun CG, Monson DK, Lopez-Aguiar AG, Le N, McInnis MR, Reimer NB, Oskouei SV, Delman KA, Staley CA, Maithel SK, Cardona K. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas. Ann Surg Oncol. 2017 Nov; 24 (12):3574-3586. PMID: 28895084.
6. Lopez-Aguiar AG, Ethun CG, Postlewait LM, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Maithel SK, Cardona K. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving its Prognostic Value for Recurrence of Disease. Ann Surg Oncol. 2018 Jan; 25(1): 290-298. PMID: 29079920.
7. Merath K, Bagante F, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Nomogram Predicting the Risk of Recurrence after Curative-Intent Resection of Primary Non-metastatic Gastrointestinal Neuroendocrine Tumors: An Analysis of the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol. 2018 Apr; 117(5):868-878. PMID: 29448303.
8. Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Martin RC, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018 May; 267(5):797-805. PMID: 29064885.
9. Lopez-Aguiar AG, Ethun CG , Le N, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin L, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Association of Perioperative Transfusion with Survival and Recurrence after Resection of Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. J Surg Oncol. 2018 Jun; 117(8):1638-1647. PMID: 29761515.
10. Oh G, Farley CR, Lopez-Aguiar AG, Russell MC, Delman KA, Lowe MC. Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin. Am Surg. 2018 Aug; 84(8):1319-1325. PMID: 30185309.
11. Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK. Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg. 2018 Sep; 227(3):357-366. PMID: 29906615.
12. Dhar VK, Merchant NB, Patel SH, Edwards MJ, Wilma K, Imbus J, Abbott DE, Weber SM, Louie R, Kim HJ, Martin RCG, Scoggins CR, Bentrem DJ, LeCompte MT, Idrees K, Lopez-Aguiar AG, Maithel SK, Kooby DA, Franco DA, Yakoub D, Ahmad SA. Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study. Ann Surg. 2018 Sep; 268(3): 469-478. PMID: 30063495.
13. Lopez-Aguiar AG, Cardona K. ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2018 Dec; 25(Suppl 3):826-827. PMID: 30456670.
14. Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. J Gastrointest Surg. 2019 Jan; 23(1):122-134. PMID 30334178.
15. Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK; and other members of the US Neuroendocrine Tumor Study Group. The Impact of Failure to Achieve Symptom Control after Resection of Functional Neuroendocrine Tumors: An 8-Institution Study from the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2019 Jan; 119(1): 5-11. PMID: 30481383.
16. Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors. JAMA Surg. 2019 Feb; 154(2):134-140. PMID: 30383112.
17. Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G, Shaffer VO, Staley CA, Srinivasan J, Maithel SK, Sullivan PS. Caution: Increased Acute Kidney Injury in Enhanced Recovery after Surgery (ERAS) Protocols. Am Surg. 2019 Feb; 85(2):156-161. PMID: 30819291.
18. Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin Status and Long-Term Prognosis of Primary Pancreatic Neuroendocrine Tumor after Curative Resection: Results from the US Neuroendocrine Tumor Study Group. Surgery. 2019 Mar; 165(3):548-556. PMID 30278986.
19. Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of Carcinoid Syndrome on the Clinical Characteristics and Outcomes of Patients with Gastroenteropancreatic Neuroendocrine Tumors undergoing Operative Resection. Surgery. 2019 Mar; 165(3):657-663. PMID: 30377003.
20. Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2019 Apr; 23(4): 651-658. PMID: 30659439.
21. Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Gastric Carcinoids: Does Type of Surgery or Tumor Affect Survival? Am J Surg. 2019 May; 217(5):937-942. PMID: 30686481.
22. Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2019 Jun; 26(6):1814-1823. PMID: 30877497.
23. Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, Fields RC, Idrees K, Cho CS, Abbott DE, Cardona K, Maithel SK. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. Surgery. 2019 Jul; 166(1): 15-21. PMID: 31072670.
24. Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group. Minimally Invasive versus Open Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: An Analysis from the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol. 2019 Aug; 120(2):231-240. PMID: 31001868.
25. Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Ann Surg Oncol. 2019 Aug; 26(8):2517-2524. PMID: 31004295.
26. Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Ann Surg. 2019 Sep; 270(3):422-433. PMID: 31283562.
27. Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC. Association of Preoperative Monocyte-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratio with Recurrence-free and Overall Survival after Resection of Pancreatic Neuroendocrine Tumors (US-NETSG). J Surg Oncol. 2019 Sep; 120(4):632-638. PMID: 31339198.
28. Duininck G, Lopez-Aguiar AG, Lee RM, Miller L, Dariushnia S, Wu C, Alese OB, Lin JY, Wedd J, Adams A, Maithel SK, Russell MC. Optimizing Cancer Care for Hepatocellular Carcinoma at a Safety-Net Hospital: The Value of a Multidisciplinary Disease Management Team. J Surg Oncol. 2019 Oct 22. doi: 10.1002/jso.25738. [Epub ahead of print]. PMID: 31642056.
29. Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. J Gastrointest Surg. 2019 Nov; 23(11):2225-2231. PMID: 30941685.
30. DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC and other members of the United States Neuroendocrine Tumor Study Group. Interaction of Race and Pathology for Neuroendocrine Tumors: Epidemiology, Natural History, or Racial Disparity? J Surg Oncol. 2019 Nov; 120(6):919-925. PMID: 31385621.
31. Lopez-Aguiar AG, Maithel SK. ASO Author Reflections: Association of Perioperative Red Blood Cell Transfusion with Increased Disease Recurrence and Worse Survival after Resection of Distal Cholangiocarcinoma. Ann Surg Oncol. 2019 Dec; 26(Suppl 3):654-655. doi: 10.1245/s10434-019-07613-3. PMID: 31286311.
32. Lopez-Aguiar AG, Maithel SK. ASO Author Reflections: Lymph Node Metastasis and the Role for Lymphadenectomy During Surgery for Nonfunctional Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2019 Dec;26(Suppl 3):700-701. doi: 10.1245/s10434-019-07746-5. PMID: 31440924.
33. Ethun CG, Lopez-Aguiar AG, Switchenko JM, Gillespie TW, Delman KA, Staley CA, Maithel SK, Cardona K. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database. Ann Surg Oncol. 2019 Dec; 26(13):4723-4729. PMID: 31502023.
34. Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. Am Surg. 2019 Dec 1;85(12):1334-1340. PMID: 31908214.
35. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM. Resection of Pancreatic Neuroendocrine tumors: Defining Patterns and Time Course of Recurrence. HPB (Oxford). 2020 Feb; 22(2):215-223. doi: 10.1016/j.hpb.2019.05.020. PMID: 31235429.
36. Lopez-Aguiar AG, Maithel SK. Response to a Letter to the Editor: “The Cononundrum of <2 cm Pancreatic Neuroendocrine Tumors: A Preoperative Risk Score to Predict Lymph Node Metastases and Guide Surgical Management.” Surgery. 2020 Feb;167(2):514-515. doi: 10.1016/j.surg.2019.09.009. PMID: 31653493.
37. Monteiro De Barros J, Hodson J, Glasbey J, Massey R, Rintoul-Hoad O, Chetan M, Desai A, Almond LM, Gourevitch D, Ford SJ, Strauss D, Smith H, Hayes A, Cardona K, Lopez-Aguiar A, Johnson A, Swallow C, Burtenshaw S, Nessim C, Weng R, Purgin B, Gronchi A, Fiore M, Callegaro D, Raut CP, Fairweather M, Bagaria S, Novak M, Gyorki D, Reid F, Mullinax J, Gonzalez RJ, Van Coevorden F, Van Houdt W, Haas RLM, Van Boven H, Heeres B. Intercontinental Collaborative Experience with Abdominal, Retroperitoneal and Pelvic Schwannomas. Br J Surg. 2020 Mar;107(4):452-463. doi: 10.1002/bjs.11376. PMID: 31736066.
38. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Ann Surg Oncol. 2020 Apr;27(4):1203-1212. doi: 10.1245/s10434-019-08120-1. PMID: 31838609.
39. Lopez-Aguiar AG, Postlewait LM, Ethun CG, Zaidi MY, Zhelnin K, Krasinskas A, Russell MC, Kooby DA, Cardona K, El-Rayes BF, Maithel SK. STAT3 Inhibition for Gastroenteropancreatic Neuroendocrine Tumors: Potential for a New Therapeutic Target? J Gastrointest Surg. 2020 May; 24(5):1138-1148. doi: 10.1007/s11605-019-04261-6. PMID: 31144189.
40. Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, Cannon J, Poultsides GA, Rocha F, Crown A, Beal E, Michael Pawlik T, Fields R, Panni RZ, Smith P, Idrees K, Cho C, Beems M, Maithel S, Weber S, Erik Abbott D. Adjuvant Therapy Following Resection of Gastroenteropancreatic Neuroendocrine Tumors Provides No Recurrence or Survival Benefit. J Surg Oncol. 2020 Jun;121(7):1067-1073. doi: 10.1002/jso.25896. PMID: 32153032.
41. Marincola Smith P, Baechle J, Solorzano CC, Tan M, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho C, Bees M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Perioperative Blood Transfusion on Survival in Pancreatic Neuroendocrine Tumor Patients: Analysis from the US Neuroendocrine Study Group. HPB (Oxford). 2020 Jul;22(7):1042-1050. doi: 10.1016/j.hpb.2019.10.2441. PMID: 31806388.
42. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Tumor Burden Score Predicts Tumor Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection. HPB (Oxford). 2020 Aug; 22(8): 1149-1157. doi: 10.1016/j.hpb.2019.11.009. PMID: 31822386.
43. Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel SK, Rocha FG. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes? J Gastrointest Surg. 2020 Sep; 24(9): 2121-2126. doi: 10.1007/s11605-019-04431-6. PMID: 31749094.
44. Marincola Smith P, Baechle J, Tan MC, Solórzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho CS, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2020 Sep; 27(9): 3147-3153. doi: 10.1245/s10434-020-08359-z. PMID: 32219725.
45. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Spolverato G, Maithel SK, Pawlik TM. Surgical Outcomes of Patients with Duodenal vs Pancreatic Neuroendocrine Tumors Following Pancreatoduodenectomy. J Surg Oncol. 2020 Sep; 122(3): 442-449. doi: 10.1002/jso.25978. PMID: 32470159.
46. Baechle JJ, Marincola Smith P, Tan M, Solórzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Makris E, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields R, Maithel SK, Bailey CE, Idrees K. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Ann Surg Oncol. 2020 Oct; 27(10): 3915-3923. doi: 10.1245/s10434-020-08497-4. PMID: 32328982.
47. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields RC, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Ann Surg Oncol. 2020 Dec; 27(Suppl 3): 969. doi: 10.1245/s10434-020-08397-7. PMID: 32342296.
48. Gamboa AC, Ethun CG, Postlewait LM, Lopez-Aguiar AG, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Cardona K, Maithel SK. HSP90 Expression and Early Recurrence in Gastroenteropancreatic Neuroendocrine Tumors: Potential for a Novel Therapeutic Target. Surg Oncol. 2020 Dec; 35: 460-465. doi: 10.1016/j.suronc.2020.09.018. PMID: 33080545.
49. Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Dillhoff M, Lopez-Aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Indications and Outcomes of Enucleation versus Formal Pancreatectomy for Pancreatic Neuroendocrine Tumors. HPB (Oxford). 2021 Mar; 23(3):413-421. doi: 10.1016/j.hpb.2020.06.015. PMID: 32771338.
50. Heidsma CM, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Poultsides GA, Cho CS, Lopez-Aguiar AG, Kanji Z, Fisher AV, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine TumorsL A Multi-Institutional Study. Cancers (Basel). 2021 May 7; 13(9):2242. doi: 10.3390/cancers13092242. PMID: 34067017.
51. Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Ann Surg. 2021 Jul 1; 274(1):e28-e35. doi: 10.1097/SLA.0000000000003478. PMID: 31356277.
52. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model. World J Surg. 2021 Jul; 45(7): 2134-2141. doi: 10.1007/s00268-021-06020-8. PMID: 33768309.
53. Sahara K, Tsilimigras DI, Moro A, Mehta R, Dillhoff M, Heidsma CM, Lopez-Aguiar AG, Maithel SK, Rocha F, Kanji Z, Abbott DE, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho CS, Beems M, Endo I, Pawlik TM. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group. Neuroendocrinology. 2021; 111(1-2): 129-138. doi: 10.1159/000506399. PMID: 32040951.
54. Casadei L, de Faria FCC, Lopez-Aguiar A, Pollock RE, Grignol V. Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma. Cancers (Basel). 2022 Mar 8; 14(6): 1362. doi: 10.3390/cancers14061362. PMID: 35326514.
55. Zheng-Pywell R, Lopez-Aguiar A, Fields RC, Vickers S, Yates C, Dudeja V, Chen H, Reddy S, Maithel SK, Rose JB. Are We Undertreating Black Patients with Nonfunctional Pancreatic Neuroendocrine Tumors? Critical Analysis of Current Surveillance Guidelines by Race. J Am Coll Surg. 2022 Apr 1; 234(4): 599-606. doi: 10.1097/XCS.0000000000000105. PMID 35380181.
56. Zhang XF, Xue F, Wu Z, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanj Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lyu Y, Maithel SK, Pawlik TM. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors. Ann Surg. 2022 Jun 1; 275(6):e773-e780. doi: 10.1097/SLA.0000000000004039. PMID: 32511134.
57. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy versus Right Hemicolectomy. J Gastrointest Surg. 2022 Jun; 26(6): 1266-1274. doi: 10.1007/s11605-022-05269-1. PMID: 35149952.
58. Grignol VP, Lopez-Aguiar AG. The Implications of an Unplanned Sarcoma Excision (the “Whoops” Operation). Surg Clin North Am. 2022 Aug; 102(4): 529-538. doi: 10.1016/j.suc.2022.04.002. PMID: 35952685.
59. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical Outcomes of Gastro-entero-pancreatic Neuroendocrine Tumors G3 versus Neuroendocrine Carcinoma. J Surg Oncol. 2022 Sep; 126(4): 689-697. doi: 10.1002/jso.26928. PMID: 35616186.
60. Makris EA, Cannon JGD, Norton JA, Lopez-Aguiar AG, Dillhoff M, Beal E, Idrees K, Smith PM, Rocha FG, Kanji Z, Cho C, Beems M, Weber S, Fisher A, Krasnick BA, Fields RC, Maithel SK, Poultsides GA. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2023 Apr; 30(4): 2424-2430. doi: 10.1245/s10434-022-12783-8. PMID: 36434481.
61. Guo M, Leuschner T, Lopez-Aguiar A, Dillhoff M, Ejaz A, Pawlik TM, Cloyd JM. Aborted Cancer Surgery at a Single Tertiary Cancer Center: Rates, Reasons, and Outcomes. Surgery. 2023 Oct; 174(4): 880-885. doi: 10.1016/j.surg.2023.06.026. PMID: 37482440.
62. Stevens L, Wells-Di Gregorio S, Lopez-Aguiar AG, Khatri R, Ejaz A, Pawlik TM, Scott E, Kale S, Cloyd JM. Patient Experiences After Aborted Cancer Surgery: A Qualitative Study. Ann Surg Oncol. 2023 Oct; 30(11): 6844-6851. doi: 10.1245/s10434-023-14046-6. PMID: 37540329.
63. Xiang JX, Qian YR, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Low Prognostic Nutritional Index is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-entero-pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2024; 114(2): 158-169. doi: 10.1159/000534075. PMID: 37703840.
64. Lopez-Aguiar AG, Sarna A, Wells-DiGregorio S, Huang E, Kneuertz PJ, Beane J, Kim A, Ejaz A, Pawlik TM, Cloyd JM. Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of a Society of Surgical Oncology Member Survey. Ann Surg Oncol. 2024 Apr; 31(4): 2295-2302. doi: 10.1245/s10434-023-14804-6. PMID: 38127216.
65. Xiang JX, Nan YL, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Preoperative Anemia: Impact on Short- and Long-term Outcomes Following Curative-Intent Resection of Gastroenteropancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2024 Jun 13:S1091-255X(24)00366-4. doi: 10.1016/j.gassur.2024.03.014. PMID: 38538480.
66. Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors. J Surg Oncol. 2025 Mar; 131(3):473-480. doi: 10.1002/jso.27951. PMID: 39387595.
67. Kesmodel SB, Lopez-Aguiar A, Grossman J, Zhao W, Koru-Sengul T, Tang J, Nouri K, Hernandez-Aya L, Lutzky J, Crystal JS. Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma. J Am Coll Surg. 2025 Oct 10. 10.1097/XCS.0000000000001657. Online ahead of print. PMID: 41071542.
68. Xu H, Hou JJ, Xiang JX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical Resection. Ann Surg Oncol. 2025 Oct 16. doi: 10.1245/s10434-025-18561-6. Online ahead of print.PMID: 41102572.
69. Xu H, Hou JJ, Xiang JX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM. ASO Visual Abstract: Perineural Invasion Worsens Long-Term Outcome of Pancreatic Neuroendocrine Tumors Following Surgical Resection. Ann Surg Oncol. 2025 Nov 11. doi: 10.1245/s10434-025-18725-4. Online ahead of print. PMID: 41217677.
70. Lopez-Aguiar AG, Xu M, Kim HG, Liebner D, Grignol VP, Tinoco G. Association Between Area Deprivation Index (ADI) and Initial Treatment Among Patients with Desmoid Tumors. Surg Oncol Insight. 2026 Mar; 3(1):100216. doi: 10.1016/j.soi.2026.100216. Epub 2026 Jan 16. PMID: 41859005.
Professional Societies
Society of Surgical Oncology
American Society of Breast Surgeons
Graduate Programs
Surgery-General
Link to this profile
https://faculty.uci.edu/profile/?facultyId=7365
https://faculty.uci.edu/profile/?facultyId=7365
Last updated
04/04/2026
04/04/2026